Actualités réglementaires
28 sept. 2026•1 min de lecture
FDA Discontinues Lactulose Oral/Rectal Solution (NDA017906)
The FDA has listed the Lactulose oral and rectal solution (product #001) as discontinued under NDA017906, sponsored by Solvay.
Actualités réglementaires
23 sept. 2026•1 min de lecture
SOLVAY's TRANMEP Tablet (Meprobamate 400mg) Discontinued – ANDA084369
FDA records show SOLVAY's oral tablet TRANMEP, containing 400 mg meprobamate, is listed as discontinued under application ANDA084369.
Actualités réglementaires
3 sept. 2026•1 min de lecture
FDA Approves ANDA083606 for Butabarital Sodium Oral Tablet
The FDA approved ANDA083606 for an oral tablet of butabarital sodium (16.2 mg) submitted by Solvay; the product is listed as discontinued.